Daiichi Sankyo, AstraZeneca apply for second EU approval for Datroway

Datroway is an antibody drug conjugate discovered by Tokyo-based pharmaceutical maker Daiichi Sankyo. It is being jointly developed and commercialised with Cambridge, England-based AstraZeneca PLC.
Globes

Compugen restructures AstraZeneca deal to boost cash coffers

Israeli drug discovery and development company Compugen (Nasdaq: CGEN; TASE: CGEN) today announced changes in its ...

AstraZeneca Gets FDA Nod For Breast Cancer Drug, EU Clearance For Lupus Pen

FDA approves AstraZeneca and Daiichi's Enhertu combo for first-line HER2-positive breast cancer, while the EU clears Saphnelo ...
Stockhead on MSN

Culture testing is becoming pharma’s next battleground, and Clever Culture has a head start

Clever Culture is quietly automating one of pharma’s most unforgiving jobs , turning a regulatory headache into a scalable ...
Agence France-Presse

DATROWAY® Type II Variation Application Validated in the EU as First-Line Treatment for Patients with Metastatic Triple Negative Breast Cancer Who are Not Candidates for ...

The European Medicines Agency (EMA) has validated the Type II Variation marketing authorization application for DATROWAY ® (datopotamab deruxtecan) as monotherapy for the first-line treatment of adult ...
Pharmabiz

AstraZeneca’s Saphnelo approved in EU for subcutaneous self-administration as a new pre-filled pen for systemic lupus erythematosus

AstraZeneca’s Saphnelo (anifrolumab) has been approved in the European Union (EU) for subcutaneous self-administration as a pre-filled pen for adult patients with systemic lupus erythematosus (SLE) on ...
TipRanks on MSN

TROPION-Lung17: New phase III lung cancer trial adds medium-term upside potential for AstraZeneca and Daiichi Sankyo

TROPION-Lung17 Clinical Update: What Investors Should Watch in AstraZeneca and Daiichi Sankyo’s Next Lung Cancer Catalyst ...
The Pharma Letter

Saphnelo approved in the EU for sc self-administration

UK pharma major AstraZeneca today revealed that Saphnelo (anifrolumab) has been approved in the European Union (EU) for ...

AstraZeneca's Saphnelo gets EU approval for self-administration

(Alliance News) - AstraZeneca PLC on Tuesday said its drug Saphnelo, or anifrolumab, has been approved in the European Union as a new pre-filled pen for systemic lupus erythematosus. The Cambridge, ...

Pfizer Plays Catchup In Obesity Market, Licenses Weight-loss Drug From Fosun

Fosun is joining the fray through its subsidiary Yao Pharma, which has granted Pfizer an exclusive worldwide license to ...
TipRanks on MSN

AstraZeneca, Daiichi Sankyo get EMA validation of Datroway type II variation MAA

The European Medicines Agency has validated the Type II Variation marketing authorization application for Datroway as monotherapy for the ...
The Pharma Letter

AstraZeneca backs Syneron Bio in near-$100m financing

British pharma major AstraZeneca (LSE: AZN) has joined a near-$100 million series A and A+ financing round for Syneron Bio, a ...